• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home 2 Minute Medicine

Preclinical detectable phase for open-angle glaucoma estimated at 10 years

byMolly Munsell
December 5, 2022
in 2 Minute Medicine, Chronic Disease, Ophthalmology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Based on a large Swedish cohort screened for open-angle glaucoma, the estimated preclinical detectable phase for glaucoma was estimated at 10.7 and 10.1 years by two different calculation methods.

2. The prevalence of open-angle glaucoma in the cohort was 1.3% at the time of screening, with an annual incidence of 0.12% for cases undetected at screening but later diagnosed clinically.

Evidence Rating Level: 2 (Good)

Study Rundown: Primary open-angle glaucoma is a leading cause of vision loss and blindness. Though past studies on population screening for glaucoma have shown mixed results, some trials have reported significant vision benefits. This study aimed to contribute information on the utility of screening efforts by reporting the length of the preclinical detectable phase (PCDP) for open-angle glaucoma. PCDP, or sojourn time, is the period in which disease can be detected on screening but not clinically. Data from about 2,000 subjects were drawn from a cohort of 33,000 Swedish patients who were screened for glaucoma then followed up for 20 to 25 years. The prevalence of open-angle glaucoma at the time of screening was 1.3%, while the clinical incidence over the follow-up period was 0.12% per year. Based on the ratio of these prevalence and incidence rates, the mean PCDP was 10.7 years. Based on an alternative calculation using Bayesian interference and a Markov chain Monte Carlo algorithm, the estimate was 10.1 years. This means that it would take, on average, 10 to 11 years for the cases detected by screening to be diagnosed clinically had the screening not taken place. Though the generalizability of these estimates to other settings is limited by the ethnic homogeneity of the cohort, this long sojourn time suggests that screening even at an interval of five or more years could have clinical utility. However, the success of a screening program relies on high screening sensitivity, achieved here using initial IOP screening followed by full workup at a subsequent visit, which presents substantial logistical challenges.

Click to read the study in JAMA Ophthalmology

Click to read an accompanying editorial in JAMA Ophthalmology

Relevant Reading: Screening for glaucoma in adults: A systematic review for the U.S. Preventive Services Task Force

RELATED REPORTS

Community-based adult vision screening program increases access to eye care

Very low-fat diet may be associated with increased glaucoma risk

Long-term variability in intraocular pressures associated with glaucoma disease progression

In-Depth [retrospective cohort]: The initial population screening was conducted between 1992 and 1997 in Sweden. At that time, intraocular pressure (IOP) and visual acuity were assessed and fundus photographs collected. All patients with IOP above 25 mmHg, suspected or evident glaucoma based on optic disc exam, retinal nerve fiber defects, optic disc hemorrhage, exfoliation syndrome, or diagnosed glaucoma in a first-degree relative returned for follow-up visits, at which Humphrey visual field measurement, tonometry, and exam were performed. Glaucoma was originally diagnosed in 427 patients based on two consecutive abnormal or borderline visual field results. Over subsequent follow-up through 2017, about 1,000 glaucoma diagnoses were made based on optic disc appearance in patients who had originally screened negative. The estimated sensitivity of screening was 94% [95% confidence interval (CI) 93-96%]. Patients who screened positive originally but did not meet diagnostic criteria for glaucoma were excluded from the analysis. The 95% CI for the PCDP estimated by the prevalence over incidence method was 8.71-13.0, while the 95% credible interval for the algorithmic method was 8.9-11.2. PCDP was longer for younger patients (aged 55-59 or 60-64).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: asymptomatic screeningexfoliative glaucomaglaucomaintraocular pressureopen angle glaucomascreening
Previous Post

Religiosity may be associated with abstinence in Latinx individuals with substance use disorders

Next Post

Overall survival with triplet therapy in BRAF V600 mutation-positive advanced melanoma

RelatedReports

Roux-en-Y gastric bypass may slow progression of diabetic retinopathy
Ophthalmology

Community-based adult vision screening program increases access to eye care

January 27, 2023
FDA-approved weight loss medications associated with weight loss at one year
Ophthalmology

Very low-fat diet may be associated with increased glaucoma risk

November 22, 2022
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Chronic Disease

Long-term variability in intraocular pressures associated with glaucoma disease progression

November 8, 2022
Roux-en-Y gastric bypass may slow progression of diabetic retinopathy
2 Minute Medicine

Rate of childhood vision screening decreased substantially between 2016 and 2020

October 5, 2022
Next Post
Complement mutation linked to poor response to eculizumab

Overall survival with triplet therapy in BRAF V600 mutation-positive advanced melanoma

Patient Basics: Brain Tumor Overview

Autologous tumour lysate-loaded dendritic cell vaccine in conjunction with standard treatment for glioblastoma may increase overall survival

2 Minute Medicine Rewind July 29, 2019

Maternal anemia in pregnancy may be associated with subsequent brain structure changes in offspring

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Concordance of diagnosis of autism spectrum disorder made by pediatricians vs multidisciplinary specialist teams
  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
  • #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options